I think it is a wonderful fit to its business model. The vast distribution channels should provide great traction. Will keenly await the roll-out of this exciting new business.
Share price took a hit yesterday and I believe the 4th query issued by SGX was the main factor.
I accept the first 3 queries from SGX may have its merits when the price moved aggressively up 20 cents level and broke through $1.00. However, as I have said before, BW is no Blumont or Liongold. The tailwinds are a successful growing business model and the potential MLM licence from China.
But this 4th query is not judiciously applied. Share price of BW has reacted positively post MLM licence approval and the subsequent announcement of a new business venture in Dental Stem Cell.
Coming from a Risk Surveillance background myself (former Head of Risk Surveillance of an International Banking Group), I believe (unless SGX has some internal information) the issuance of the 4th query was not justified and has done harm to BW and its shareholders.